JAK2 and urinary bladder carcinoma: Further validation and signaling pathway analyses revealed that ox-LDL binds to the bladder cancer cell membrane receptor CD36 and affects the intracellular JAK2-STAT3 signaling pathway, thereby regulating tumor cell stemness-related genes and promoting bladder cancer cell proliferation.